(RMBS) Rambus - Overview
Stock: Memory Interface Chips, Silicon IP, Security IP, Interface IP
| Risk 5d forecast | |
|---|---|
| Volatility | 67.3% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 30.44 |
| Character TTM | |
|---|---|
| Beta | 2.082 |
| Beta Downside | 2.743 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.83% |
| CAGR/Max DD | 0.68 |
EPS (Earnings per Share)
Revenue
Description: RMBS Rambus January 08, 2026
Rambus Inc. (NASDAQ:RMBS) designs and sells semiconductor components across the United States, South Korea, Singapore, and other international markets. Its product slate includes DDR5 and DDR4 memory-interface chips-such as registering clock drivers, multiplexed data buffers, power-management ICs, SPD hubs, temperature sensors, and client clock drivers-as well as silicon IP that addresses high-speed memory, chip-to-chip controllers, and security functions (crypto cores, hardware roots of trust, protocol engines, and provisioning technologies). The firm also monetizes a broad patent portfolio covering memory architecture, high-speed serial links, and security solutions, selling primarily to memory-module makers, OEMs, hyperscalers, and other chip vendors through a mix of direct sales and distributors.
**Key operating metrics (FY 2024, estimated):** Revenue of roughly $1.2 billion, with DDR5-related sales growing ≈ 35 % YoY as data-center demand for higher bandwidth accelerates; R&D spend near $150 million (≈ 12 % of revenue), reflecting the capital-intensive nature of IP development. **Sector drivers** include the global memory market’s projected CAGR of ~ 6 % through 2028, the rollout of AI-focused servers that favor DDR5, and macro-level supply-chain tightening that can elevate pricing power for niche IP licensors. **Economic exposure** is tied to hyperscaler capex cycles and government defense budgets, both of which have shown resilience despite broader semiconductor cyclicality.
Given these dynamics, a deeper quantitative assessment-such as a forward-looking valuation model that incorporates DDR5 adoption curves and IP licensing margins-can be explored on ValueRay, where you’ll find tools to test the sensitivity of Rambus’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 230.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 6.90 > 1.0 |
| NWC/Revenue: 122.7% < 20% (prev 109.3%; Δ 13.39% < -1%) |
| CFO/TA 0.24 > 3% & CFO 360.0m > Net Income 230.5m |
| Net Debt (-139.2m) to EBITDA (314.1m): -0.44 < 3 |
| Current Ratio: 8.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.7m) vs 12m ago 0.63% < -2% |
| Gross Margin: 75.97% > 18% (prev 0.75%; Δ 7521 % > 0.5%) |
| Asset Turnover: 49.27% > 50% (prev 41.44%; Δ 7.82% > 0%) |
| Interest Coverage Ratio: 149.9 > 6 (EBITDA TTM 314.1m / Interest Expense TTM 1.37m) |
Altman Z'' 10.00
| A: 0.57 (Total Current Assets 988.8m - Total Current Liabilities 120.6m) / Total Assets 1.53b |
| B: 0.01 (Retained Earnings 13.0m / Total Assets 1.53b) |
| C: 0.14 (EBIT TTM 205.8m / Avg Total Assets 1.44b) |
| D: 8.26 (Book Value of Equity 1.36b / Total Liabilities 165.1m) |
| Altman-Z'' Score: 13.39 = AAA |
Beneish M -3.24
| DSRI: 0.87 (Receivables 162.7m/147.9m, Revenue 707.6m/556.6m) |
| GMI: 0.99 (GM 75.97% / 75.44%) |
| AQI: 0.65 (AQ_t 0.27 / AQ_t-1 0.41) |
| SGI: 1.27 (Revenue 707.6m / 556.6m) |
| TATA: -0.08 (NI 230.5m - CFO 360.0m) / TA 1.53b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of RMBS shares?
Over the past week, the price has changed by +0.68%, over one month by -17.74%, over three months by +10.66% and over the past year by +70.61%.
Is RMBS a buy, sell or hold?
- StrongBuy: 7
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RMBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118.9 | 15.8% |
| Analysts Target Price | 118.9 | 15.8% |
RMBS Fundamental Data Overview February 21, 2026
P/E Forward = 20.4499
P/S = 15.8411
P/B = 8.0452
P/EG = 3.8007
Revenue TTM = 707.6m USD
EBIT TTM = 205.8m USD
EBITDA TTM = 314.1m USD
Long Term Debt = 37.3m USD (estimated: total debt 43.7m - short term 6.31m)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 43.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -139.2m USD (from netDebt column, last quarter)
Enterprise Value = 10.49b USD (11.21b + Debt 43.7m - CCE 761.8m)
Interest Coverage Ratio = 149.9 (Ebit TTM 205.8m / Interest Expense TTM 1.37m)
EV/FCF = 31.49x (Enterprise Value 10.49b / FCF TTM 333.2m)
FCF Yield = 3.18% (FCF TTM 333.2m / Enterprise Value 10.49b)
FCF Margin = 47.08% (FCF TTM 333.2m / Revenue TTM 707.6m)
Net Margin = 32.57% (Net Income TTM 230.5m / Revenue TTM 707.6m)
Gross Margin = 75.97% ((Revenue TTM 707.6m - Cost of Revenue TTM 170.1m) / Revenue TTM)
Gross Margin QoQ = 78.86% (prev 74.43%)
Tobins Q-Ratio = 6.86 (Enterprise Value 10.49b / Total Assets 1.53b)
Interest Expense / Debt = 0.73% (Interest Expense 320.0k / Debt 43.7m)
Taxrate = 17.31% (13.4m / 77.2m)
NOPAT = 170.2m (EBIT 205.8m * (1 - 17.31%))
Current Ratio = 8.20 (Total Current Assets 988.8m / Total Current Liabilities 120.6m)
Debt / Equity = 0.03 (Debt 43.7m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.44 (Net Debt -139.2m / EBITDA 314.1m)
Debt / FCF = -0.42 (Net Debt -139.2m / FCF TTM 333.2m)
Total Stockholder Equity = 1.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.04% (Net Income 230.5m / Total Assets 1.53b)
RoE = 18.29% (Net Income TTM 230.5m / Total Stockholder Equity 1.26b)
RoCE = 15.86% (EBIT 205.8m / Capital Employed (Equity 1.26b + L.T.Debt 37.3m))
RoIC = 13.89% (NOPAT 170.2m / Invested Capital 1.23b)
WACC = 14.20% (E(11.21b)/V(11.25b) * Re(14.25%) + D(43.7m)/V(11.25b) * Rd(0.73%) * (1-Tc(0.17)))
Discount Rate = 14.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.16%
[DCF Debug] Terminal Value 60.49% ; FCFF base≈279.9m ; Y1≈303.0m ; Y5≈376.1m
Fair Price DCF = 28.38 (EV 2.92b - Net Debt -139.2m = Equity 3.06b / Shares 107.7m; r=14.20% [WACC]; 5y FCF grow 9.38% → 2.90% )
EPS Correlation: 47.11 | EPS CAGR: 140.0% | SUE: -1.18 | # QB: 0
Revenue Correlation: 90.78 | Revenue CAGR: 19.01% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.51 | Chg30d=-0.028 | Revisions Net=-1 | Analysts=6
EPS current Year (2026-12-31): EPS=2.47 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+17.1% | Growth Revenue=+14.3%
EPS next Year (2027-12-31): EPS=3.06 | Chg30d=-0.092 | Revisions Net=+0 | Growth EPS=+23.7% | Growth Revenue=+16.0%